Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and imatinib mesylate

resveratrol has been researched along with imatinib mesylate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Auberger, P; Belhacene, N; Cassuto, JP; Colosetti, P; Grosso, S; Jacquel, A; Puissant, A1
Auberger, P; Cassuto, JP; Fenouille, N; Luciano, F; Puissant, A; Raynaud, S; Robert, G1
El-Agamy, DS; Said, SA; Shebl, AM1
Chao, KS; Chen, YJ; Hou, MH; Jhih Cai, C; Liao, HF; Su, YC; Zheng, ZY1
Baran, Y; Cakir, Z; Can, G; Gunduz, U; Kartal, M1
Li, YH; Wang, XJ1
He, BS; Hu, R; Li, Y; Liu, ML; Ruan, XL; Wang, B; Wang, J; Yang, YH; Zhu, J1

Other Studies

8 other study(ies) available for resveratrol and imatinib mesylate

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Caspases; Cell Differentiation; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Resveratrol; Stilbenes

2008
Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.
    Cancer research, 2010, Feb-01, Volume: 70, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Amino Acid Chloromethyl Ketones; AMP-Activated Protein Kinases; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Benzamides; Blotting, Western; Caspase Inhibitors; Caspases; Cell Survival; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrolides; Microscopy, Confocal; Microscopy, Electron; Piperazines; Pyrimidines; Resveratrol; RNA Interference; Sequestosome-1 Protein; Stilbenes; Tumor Cells, Cultured; Vacuolar Proton-Translocating ATPases

2010
Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice.
    Inflammopharmacology, 2011, Volume: 19, Issue:6

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzamides; Bilirubin; Curcumin; Hydroxyproline; Imatinib Mesylate; Liver; Liver Cirrhosis; Male; Mice; Piperazines; Pyrimidines; Resveratrol; Schistosoma mansoni; Schistosomiasis mansoni; Serum Albumin; Stilbenes

2011
Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:5

    Topics: Antineoplastic Agents; Benzamides; Cell Survival; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Hedgehog Proteins; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Resveratrol; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Stilbenes; Up-Regulation

2012
Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells.
    Anticancer research, 2012, Volume: 32, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Caspase 7; Cell Growth Processes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potential, Mitochondrial; Piperazines; Pyrimidines; Resveratrol; Stilbenes

2012
Inhibition of human chronic myelogenous leukemia K562 cell growth following combination treatment with resveratrol and imatinib mesylate.
    Genetics and molecular research : GMR, 2015, Jun-11, Volume: 14, Issue:2

    Topics: Apoptosis; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Resveratrol; Stilbenes

2015
An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening.
    Military Medical Research, 2022, 09-22, Volume: 9, Issue:1

    Topics: Clone Cells; Cloning, Molecular; Early Detection of Cancer; Humans; Imatinib Mesylate; Leukemia; Microfluidics; Resveratrol

2022